72 related articles for article (PubMed ID: 7556265)
1. Differential influences of carnitine palmitoyltransferase-1 inhibition and hyperthyroidism on cardiac growth and sarcoplasmic reticulum phosphorylation.
Vetter R; Kott M; Rupp H
Eur Heart J; 1995 May; 16 Suppl C():15-9. PubMed ID: 7556265
[TBL] [Abstract][Full Text] [Related]
2. Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir.
Rupp H; Schulze W; Vetter R
Am J Physiol; 1995 Sep; 269(3 Pt 2):R630-40. PubMed ID: 7573566
[TBL] [Abstract][Full Text] [Related]
3. CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins.
Vetter R; Rupp H
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2091-9. PubMed ID: 7810710
[TBL] [Abstract][Full Text] [Related]
4. Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure.
Rupp H; Vetter R
Br J Pharmacol; 2000 Dec; 131(8):1748-56. PubMed ID: 11139455
[TBL] [Abstract][Full Text] [Related]
5. Early postnatal changes in sarcoplasmic reticulum calcium transport function in spontaneously hypertensive rats.
Freestone N; Singh J; Krause EG; Vetter R
Mol Cell Biochem; 1996; 163-164():57-66. PubMed ID: 8974040
[TBL] [Abstract][Full Text] [Related]
6. Influence of diet and carnitine palmitoyltransferase I inhibition on myosin and sarcoplasmic reticulum.
Rupp H; Wahl R; Hansen M
J Appl Physiol (1985); 1992 Jan; 72(1):352-60. PubMed ID: 1537736
[TBL] [Abstract][Full Text] [Related]
7. Etomoxir improves left ventricular performance of pressure-overloaded rat heart.
Turcani M; Rupp H
Circulation; 1997 Nov; 96(10):3681-6. PubMed ID: 9396471
[TBL] [Abstract][Full Text] [Related]
8. Enhanced phosphorylation of myocardial sarcoplasmic reticulum in experimental hyperthyroidism.
Limas CJ
Am J Physiol; 1978 Apr; 234(4):H426-31. PubMed ID: 206150
[TBL] [Abstract][Full Text] [Related]
9. Sarcoplasmic reticulum Ca2+ transport and long chain acylcarnitines in hyperthyroidism.
Black SC; McNeill JH; Katz S
Can J Physiol Pharmacol; 1988 Feb; 66(2):159-65. PubMed ID: 3370547
[TBL] [Abstract][Full Text] [Related]
10. Defective calcium transport by cardiac sarcoplasmic reticulum in spontaneously hypertensive rats.
Limas CJ; Cohn JN
Circ Res; 1977 May; 40(5 Suppl 1):I62-9. PubMed ID: 192487
[TBL] [Abstract][Full Text] [Related]
11. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor.
Rupp H; Elimban V; Dhalla NS
FASEB J; 1992 Mar; 6(6):2349-53. PubMed ID: 1531968
[TBL] [Abstract][Full Text] [Related]
12. Ontogeny of sarcoplasmic reticulum protein phosphorylation by Ca2+--calmodulin-dependent protein kinase.
Xu A; Hawkins C; Narayanan N
J Mol Cell Cardiol; 1997 Jan; 29(1):405-18. PubMed ID: 9040054
[TBL] [Abstract][Full Text] [Related]
13. Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats.
Günther J; Wagner K; Theres H; Schimke I; Born A; Scholz H; Vetter R
Eur J Pharmacol; 2000 Oct; 406(1):123-6. PubMed ID: 11011043
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.
Zarain-Herzberg A; Rupp H
Expert Opin Investig Drugs; 2002 Mar; 11(3):345-56. PubMed ID: 11866664
[TBL] [Abstract][Full Text] [Related]
15. Anti-phospholamban and protein kinase A alter the Ca2+ sensitivity and maximum velocity of Ca2+ uptake by the cardiac sarcoplasmic reticulum.
Kargacin ME; Ali Z; Kargacin G
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):245-9. PubMed ID: 9512486
[TBL] [Abstract][Full Text] [Related]
16. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir.
Zarain-Herzberg A; Rupp H; Elimban V; Dhalla NS
FASEB J; 1996 Sep; 10(11):1303-9. PubMed ID: 8836044
[TBL] [Abstract][Full Text] [Related]
17. Alterations of contractility and sarcoplasmic reticulum function of rat heart in experimental hypo- and hyperthyroidism.
Takács IE; Szabó J; Nosztray K; Szentmiklósi AJ; Cseppentö A; Szegi J
Gen Physiol Biophys; 1985 Jun; 4(3):271-8. PubMed ID: 3161777
[TBL] [Abstract][Full Text] [Related]
18. Possible mechanism of the potent vasoconstrictor actions of ryanodine on femoral arteries from spontaneously hypertensive rats.
Asano M; Kuwako M; Nomura Y; Ito KM; Ito K; Uyama Y; Imaizumi Y; Watanabe M
Br J Pharmacol; 1996 Jun; 118(4):1019-27. PubMed ID: 8799577
[TBL] [Abstract][Full Text] [Related]
19. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
[TBL] [Abstract][Full Text] [Related]
20. Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene.
Tschöpe C; Spillmann F; Rehfeld U; Koch M; Westermann D; Altmann C; Dendorfer A; Walther T; Bader M; Paul M; Schultheiss HP; Vetter R
FASEB J; 2004 Dec; 18(15):1967-9. PubMed ID: 15448111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
